[This Week's IPO] October Fourth Week Demand Forecast and Subscription Schedule

In the fourth week of this month (October), Nomus, Orum Therapeutics, Three Billion, and Dotmill will conduct demand forecasting for institutional investors. Seongwoo, Aelux, Toprun Total Solution, Airain, and HEM Pharma are preparing for general subscription.

◆Nomus= Nomus showcased content delivering the know-how and philosophy of various artists through the Wonderwall class in its early days. It plans and produces artists' MD and brands directly, sells them through its own shopping mall, and provides all processes including distribution and customer service in an integrated manner.

It will offer 1.13 million shares entirely as new shares. The desired public offering price per share is KRW 27,200 to KRW 30,200, with a total expected offering amount of approximately KRW 30.7 billion to KRW 34.1 billion. The demand forecasting for institutions will be conducted over five business days from the 23rd to the 29th, followed by a two-day general subscription from November 4th. The company aims to be listed in November. The underwriter is Daishin Securities.

◆Orum Therapeutics= Orum Therapeutics is a leading bio company in the antibody-degrading drug conjugate (DAC) field based on the dual precision targeted protein degradation approach ‘TPD²®’. DAC is gaining attention as a next-generation modality that selectively delivers targeted protein degraders (TPD) to target cells through antibodies and degrades target proteins inside cells.

The total number of shares offered is 3 million. The desired public offering price range per share is KRW 30,000 to KRW 36,000. The total fundraising is expected to be KRW 90 billion based on the lower end of the price range. Demand forecasting will be conducted from the 24th to the 30th, with the public offering price to be finalized afterward. The public subscription will take place over two days on November 5th and 6th. The underwriter is Korea Investment & Securities.

◆Three Billion= Three Billion’s core technology is AI (artificial intelligence), which interprets the pathogenicity of 100,000 genetic variants of patients with 99.4% accuracy within 5 minutes and identifies the top 5 causative genetic variants of patients' diseases with 98.1% accuracy. Based on this technology, it operates an AI rare genetic disease diagnostic testing platform. The company is engaged in rare genetic disease diagnostic testing, specific disease diagnostic testing support, data-based diagnostic testing, and SaaS-type software subscription services.

It will offer a total of 3.2 million shares. The expected public offering price is KRW 4,500 to KRW 6,500, with an expected offering amount of KRW 14.4 billion to KRW 20.8 billion. Demand forecasting will be conducted over five business days from the 24th to the 30th, followed by subscription on November 5th and 6th. The company plans to be listed on the KOSDAQ market within November. The underwriter is Korea Investment & Securities.

◆Dotmill= Since its establishment in 2015, Dotmill has rapidly grown by presenting immersive content that combines analog and immersive media technology in a new paradigm. Its main business areas include project orders and the construction and operation of its own theme parks using immersive media. Leveraging its one-stop solution strength, it creates diverse business opportunities covering B2B, B2G, and B2C customers, standing out in the immersive media market.

It will offer a total of 1.2 million shares. The desired public offering price is KRW 11,000 to KRW 13,000. Demand forecasting will be conducted from the 24th to the 30th, with general subscription on November 4th and 5th. The underwriter is Mirae Asset Securities.

◆Seongwoo= The public offering price was finalized at KRW 32,000, exceeding the upper limit of the desired band (KRW 29,000). A total of 2,327 domestic and foreign institutions participated, recording a competition rate of 516 to 1. The total offering amount is KRW 96 billion, and the market capitalization after listing is about KRW 481.5 billion. General subscription will be held on the 21st and 22nd, with listing on the KOSDAQ market scheduled for the 31st. The underwriter is Korea Investment & Securities.

Seongwoo, established in 1992, produces cylindrical secondary battery parts, ESS parts, and automotive electronic parts based on its long-standing experience, ultra-precision press molding technology, and advanced quality control technology.

◆Aelux= The desired public offering price range is KRW 11,500 to KRW 13,500, with a total offering amount of KRW 17.2 billion to KRW 20.3 billion. Institutional demand forecasting was conducted until the 17th, and general subscription will be held over two days on the 23rd and 24th. The underwriter is Korea Investment & Securities.

Aelux is a specialized company producing drones and educational robots with its own technology. With the growing importance of software development education including coding, it has focused on developing and producing educational robots since its establishment and recently expanded its competitiveness by entering the drone market in earnest.

◆Toprun Total Solution= The desired public offering price is KRW 12,000 to KRW 14,000, with a total offering amount of KRW 30 billion to KRW 35 billion. Demand forecasting was conducted over five days until the 18th, and general subscription will be held on the 23rd and 24th. The underwriter is KB Securities.

Founded in 2004, Toprun Total Solution is a global Automotive & Display advanced parts ODM specialized company that develops and manufactures various electronic components such as automotive displays and IT/mobile parts. The company has grown its scale by expanding its business areas in IT parts used in daily life, including automotive, smartphones, and TVs, based on display backlight design and manufacturing technology.

◆Airain= The desired public offering price is KRW 16,000 to KRW 18,500, with a total offering amount of KRW 19.2 billion to KRW 22.2 billion. Demand forecasting will be conducted until the 21st, followed by general subscription on the 24th and 25th. The company aims to be listed on the KOSDAQ market within November. The underwriter is Shinyoung Securities.

Airain is the only domestic company developing and manufacturing membrane (hollow fiber) based gas separation membranes. The company possesses technology to selectively separate gases such as nitrogen, methane, and carbon dioxide through its self-developed gas separation membranes.

◆HEM Pharma= The desired public offering price range is KRW 16,400 to KRW 19,000. After finalizing the public offering price through demand forecasting for institutional investors, the public subscription will be conducted over two days starting from the 24th. The lead underwriter is Shinhan Investment Corp.

HEM Pharma is a global microbiome specialized company operating a personalized healthcare and LBP (Live Biotherapeutic Products) discovery platform business based on its proprietary patented technology PMAS (Personalized Pharmaceutical Metal-Analytical Screening).